Welcome to the Press center. Here’s where we take a closer look at research and development stories, trends and developments shaping the diverse areas in which our customers and partners work.
12 November 2021Human DNA contamination is still the major bottleneck in microbiology. Fast and efficient human DNA removal opens doors toward more accurate and timely diagnostics of infectious diseases which can help save lives of millions of patients. We prepared comprehensive review with analysis of most used techniques available on the market, compared their efficacy and outlined perspective of human DNA depletion for mNGS application in rapid pathogen detection. You can download and read it now.
10 May 2022We are happy to announce that Micronbrane Medical was selected by SOSA for IP2 Scaleout Program in USA. IP2 Scaleout Program is 14 months intensive accelerator program for CEO & founders that are eager to launch, grow and scale their businesses of innovative products and technologies on the global markets. Micronbrane Medical thanks SOSA and i2i for support and trust.
4 May 2022We are happy to announce that Micronbrane Medical was chosen to join and present Taiwan at SelectUSA 2022 Event!
4 May 2022Access poster and online video presentation of Micronbrane Medical and materials of other participants of ECCMID 2022 in the Online Library of ESCMID!
22 April 2022We are happy to announce that Micronbrane Medical was chosen to present poster in Poster Session at ECCMID 2022 in Lisbon Portugal in the section "Microbiome studies, clinical and diagnostic studies and One Health aspects"
15 April 2022Nowadays there are several methods of human DNA removal, including differential cell size-based methods, chemical/enzymatic treatment methods etc. In this article we overview human methylated DNA removal methods and compare their efficacy with recently launched Devin® filter from Micronbrane Medical.